CYP19A1 (aromatase) is the key enzyme taking part in the process of the conversion of androgens to estrogens thus considering as a major target for treatment of certain types of tumors, especially hormone dependent breast cancer. The purpose of this study is to achieve human aromatase (CYP19A1) from harmonized sequence and identify structural significance of rare codons, involved in the process of codon harmonization. There are several examples of influence of codon harmonization on the protein production and its activity, but these researches didn't include studying any human CYPs, which are difficult-to-produce membrane proteins. The aim of our study is to combine methods of codon harmonization, usage of optimal expression system and conditions, and modifications to the standard purification protocol in order to increase the yield of purified human recombinant aromatase for further usage of the enzyme for the screening of new inhibitors. In our research the structural significance of rare codons for the formation of the secondary structure is revealed, which is implemented in the algorithm of codon harmonization in human aromatase sequence. The combined approach with codon harmonization technique and one-step purification enables to achieve over 300 nmol of homogeneous, catalytically active human CYP19A1 per Liter of culture. We expect the results obtained will provide valuable information for protein engineering and enzymology.
扫码关注我们
求助内容:
应助结果提醒方式:
